Vice President, mRNA CDMO

Danaher•Fargo, ND

3d•Remote

About The Position

The Vice President, mRNA CDMO provides strategic and operational leadership for Aldevron’s mRNA business. The role is accountable for the mRNA portfolio’s growth, profitability, performance, and long-term business outcomes. It defines portfolio priorities, investment decisions, pricing strategies, lifecycle plans, and future roadmaps based on customer needs, market opportunities, competitive intelligence, emerging technologies, and business objectives. The Vice President builds and develops a high-performing product management organization through managers and senior leaders, while establishing governance processes that connect product strategy with operating plans, revenue growth, margin improvement, innovation, and operational readiness. The role works across Commercial, R&D, Operations, Finance, Quality, Regulatory, and Strategy, and serves as the executive spokesperson for the mRNA portfolio with senior stakeholders, customers, and industry partners. The position reports to the Vice President, Business Unit & General Manager CDMO. It is part of the Aldevron Business Unit, is associated with Fargo, North Dakota, and is fully remote.

Requirements

Bachelor’s degree in Life Sciences, Business, or a related field.
13 or more years of experience in product management, strategic marketing, commercial leadership, business strategy, or general management within life sciences, bioprocessing, genomic medicine, CDMO, mRNA, nucleic acids, biologics, or related markets.
Demonstrated experience leading managers and senior professionals in a complex, matrixed business environment.
Proven ability to develop and execute portfolio strategy, product lifecycle management, market-back planning, and cross-functional governance processes.
Strong business and commercial acumen, including experience driving revenue growth, profitability, customer value, and competitive differentiation.
Track record of influencing senior stakeholders and leading strategic decision making across Commercial, R&D, Operations, Finance, Quality, Regulatory, and other cross-functional teams.
Experience resolving complex business challenges that balance customer, technical, operational, regulatory, financial, and commercial considerations.

Nice To Haves

MBA or advanced degree.
FDA-regulated industry experience.
Direct experience leading mRNA, genomic medicine, cell and gene therapy, biologics, or advanced therapeutics portfolios in a CDMO, biotech, or life sciences environment.
Prior senior-level accountability with demonstrated success driving business growth, profitability, and strategic investment decisions.
Experience leading global commercial expansion, portfolio transformation, acquisitions or integrations, or new market entry initiatives within a highly regulated industry.

Responsibilities

Define and execute the strategic direction for the mRNA portfolio, with accountability for growth, profitability, portfolio performance, and long-term business outcomes.
Establish portfolio priorities, investment decisions, pricing strategies, and lifecycle plans aligned with customer needs, market opportunities, and business objectives.
Translate customer insights, competitive intelligence, emerging technologies, and industry trends into differentiated value propositions and future portfolio roadmaps.
Build, coach, and develop a high-performing product management team through managers and senior leaders, supporting talent, succession planning, and organizational capability.
Establish governance processes connecting product strategy to operating plans, revenue growth, margin improvement, innovation priorities, and operational readiness.
Partner with Commercial, R&D, Operations, Finance, Quality, Regulatory, and Strategy leaders to align resources, investments, capacity plans, and execution priorities.
Serve as executive spokesperson for the mRNA portfolio, influencing senior stakeholders, leading strategic decision making, and engaging key customers and industry partners.